Capsigen is a leader in the engineering of AAV capsids for use in gene therapies, opening the path to permanent cures for patients suffering from intractable illness. Capsigen is enabling a new era of genetic medicines based on a disease-first approach. Powered by our TRADE™ and data science platforms, we engineer vectors with the highest possible potency and cell-type specificity. Developing genetic medicines that are tailored to the unique biology involved in the disease ensures that the therapy can bring the maximum benefit to patients. Our team is driven in its pursuit to deliver on this promise to the millions of people depending on the advancement of science to discover new cures.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Vancouver, Wa, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.capsigen.com
- HQ
- Vancouver, WA
Capsigen Questions
Capsigen's website is http://www.capsigen.com
Capsigen's LinkedIn profile is https://www.linkedin.com/company/capsigen
Capsigen has
5 employees.
View email and phone details for 5
employees at Capsigen.
Capsigen's industry is
Biotechnology Research
Capsigen's top competitors are
Absci,
Oregon Bioscience Association,
Pdx Pharmaceuticals,
Ubivac,
Invivo Biosystems,
Twist Bioscience,
Sedia Biosciences Corp.,
Birch Biosciences,
Trace Biosciences,
Floragenex, Inc..
Capsigen's categories are Biotechnology Research
Capsigen's founding year is 2020
